FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77821
News■ Unclear/unknown
Longevity Health Earns 5-Star CMS Ratings Across Portfolio for Second Consecutive Year
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Medicare Advantage star ratings affect plan quality bonuses, but this is a private plan operator.
Medicare Advantage quality scores, private issuer
CATALYST TO WATCH
CMS rating cycle updates
MAIN RISK
Ratings can fall next cycle
FULL DISPATCH
PALM BEACH GARDENS, Fla., Oct. 13, 2026 /PRNewswire/ -- Longevity Health announced today that all five of its eligible health plans (Longevity Health of Illinois, Florida, Michigan, New Jersey and North Carolina) earned an overall 5-Star rating from the Centers for Medicare & Medicaid...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation2026-10-13 14:31 UTC
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation2026-10-13 14:31 UTC
→CORRELATIONshares Healthcare
EU approves Kimberly-Clark's acquisition of Kenvue, subject to conditions2026-10-13 14:16 UTC
EU approves Kimberly-Clark's acquisition of Kenvue, subject to conditions2026-10-13 14:16 UTC
→CORRELATIONshares Healthcare
‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks2026-10-13 15:17 UTC
‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks2026-10-13 15:17 UTC
←CORRELATIONshares Healthcare
The Argument For Biotech M&A To Reignite... And Soon2026-10-13 12:00 UTC
The Argument For Biotech M&A To Reignite... And Soon2026-10-13 12:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.